TMCI
Income statement / Annual
Last year (2023), Treace Medical Concepts, Inc.'s total revenue was $187.12 M,
an increase of 31.92% from the previous year.
In 2023, Treace Medical Concepts, Inc.'s net income was -$49.53 M.
See Treace Medical Concepts, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$187.12 M
|
$141.84 M
|
$94.42 M
|
$57.37 M
|
$39.42 M
|
| Cost of Revenue |
$35.18 M |
$27.52 M |
$17.83 M |
$12.47 M |
$7.63 M |
| Gross Profit |
$151.94 M |
$114.32 M |
$76.59 M |
$44.90 M |
$31.79 M |
| Gross Profit Ratio |
0.81 |
0.81 |
0.81 |
0.78 |
0.81 |
| Research and Development
Expenses |
$15.44 M
|
$13.58 M
|
$10.20 M
|
$5.85 M
|
$5.07 M
|
| General & Administrative
Expenses |
$47.03 M
|
$33.00 M
|
$18.43 M
|
$6.54 M
|
$4.46 M
|
| Selling & Marketing
Expenses |
$140.89 M
|
$102.58 M
|
$64.47 M
|
$31.65 M
|
$25.79 M
|
| Selling, General &
Administrative Expenses |
$187.93 M
|
$135.58 M
|
$82.90 M
|
$38.19 M
|
$30.25 M
|
| Other Expenses |
$0.00 |
-$403,000.00 |
$1,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$203.37 M |
$149.16 M |
$93.10 M |
$44.04 M |
$35.32 M |
| Cost And Expenses |
$238.55 M |
$176.68 M |
$110.93 M |
$56.51 M |
$42.95 M |
| Interest Income |
$6.73 M |
$910,000.00 |
$18,000.00 |
$2.78 M |
$111,000.00 |
| Interest Expense |
$5.17 M |
$4.40 M |
$4.06 M |
$2.78 M |
$841,000.00 |
| Depreciation &
Amortization |
$5.35 M
|
$4.66 M
|
$685,000.00
|
$1.21 M
|
$793,000.00
|
| EBITDA |
-$39.01 M
|
-$34.84 M
|
-$15.81 M
|
$2.07 M
|
-$2.63 M
|
| EBITDA Ratio |
-0.21 |
-0.22 |
-0.17 |
0.01 |
-0.07 |
| Operating Income Ratio
|
-0.27
|
-0.25
|
-0.17
|
-0.02
|
-0.09
|
| Total Other
Income/Expenses Net |
$1.90 M
|
-$7.97 M
|
-$4.04 M
|
-$4.52 M
|
-$730,000.00
|
| Income Before Tax |
-$49.53 M |
-$42.82 M |
-$20.55 M |
-$3.67 M |
-$4.27 M |
| Income Before Tax Ratio
|
-0.26
|
-0.3
|
-0.22
|
-0.06
|
-0.11
|
| Income Tax Expense |
$0.00 |
$4.48 M |
$4.06 M |
$2.78 M |
$841,000.00 |
| Net Income |
-$49.53 M |
-$47.30 M |
-$24.61 M |
-$6.45 M |
-$5.11 M |
| Net Income Ratio |
-0.26 |
-0.33 |
-0.26 |
-0.11 |
-0.13 |
| EPS |
-0.81 |
-0.86 |
-0.45 |
-0.13 |
-0.0998 |
| EPS Diluted |
-0.81 |
-0.86 |
-0.45 |
-0.13 |
-0.0998 |
| Weighted Average Shares
Out |
$60.85 M
|
$55.28 M
|
$54.18 M
|
$51.17 M
|
$51.17 M
|
| Weighted Average Shares
Out Diluted |
$60.85 M
|
$55.28 M
|
$54.18 M
|
$51.17 M
|
$51.17 M
|
| Link |
|
|
|
|
|
